Literature DB >> 11227599

Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias.

M Greene1, D Newman, M Geist, M Paquette, D Heng, P Dorian.   

Abstract

BACKGROUND: Electrical storm in patients with implanted cardioverter defibrillators (ICDs) is purported to carry an ominous prognosis. METHODS AND
RESULTS: We retrospectively compared 40 patients with electrical storm (defined as three or more episodes of ventricular arrhythmia requiring ICD therapy in a 24 h period) with those only having isolated appropriate ICD therapy (n=57) and with patients having no or only inappropriate ICD therapy (n=125). All patients received ICDs for documented sustained VT or VF. There was no significant difference in age, sex, ejection fraction, total follow-up time, or underlying heart disease between any of the three groups. Patients who had electrical storm received their first appropriate ICD therapy 275 +/- 369 days post-implant (35% had storm as their first event) with storm occurring an average of 599 +/- 710 days post-implant. Patients had 1.5 +/- 1.0 storms in total (median= 1), with 55 +/- 91 episodes per storm. There were no significant differences in actuarial survival at 5-year follow-up between the three groups. Eighty percent of storm patients were alive 5 years post-implant.
CONCLUSION: Storm is a common occurrence in ICD patients, can occur at any time during the follow-up period, and does not independently confer increased mortality.

Entities:  

Mesh:

Year:  2000        PMID: 11227599     DOI: 10.1053/eupc.2000.0104

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  22 in total

Review 1.  [Incessant or recurrent ventricular tachycardia. Indications for emergency ablation].

Authors:  R Surber; D Prochnau; H Kühnert; H R Figulla
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-04-22       Impact factor: 0.840

2.  [Home monitoring of an incessant VT in an ICD patient].

Authors:  N Reinsch; D Woydowski; H Schön; M Buddensiek; W Weissenberger; R Erbel; T Konorza
Journal:  Herz       Date:  2010-12-23       Impact factor: 1.443

Review 3.  Electrical storm in patients with an implanted defibrillator: a matter of definition.

Authors:  Carsten W Israel; S Serge Barold
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-10       Impact factor: 1.468

4.  Clinical benefit, survival and adverse events in patients with implantable cardioverter defibrillators: the initial Rotterdam experience.

Authors:  D A M J Theuns; A P J Klootwijk; G P Kimman; M L Simoons; J R T C Roelandt; L J L M Jordaens
Journal:  Neth Heart J       Date:  2001-09       Impact factor: 2.380

5.  [Electrical storm: definition, prevalence, causes and prognostic implications].

Authors:  Carsten W Israel; Johannes C Manegold
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-07-01

6.  [Catheter ablation for the treatment of electrical storm: methods and outcome].

Authors:  Erik Wißner; Bruno Reißmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-06-05

Review 7.  Electrical Storm: Incidence, Prognosis and Therapy.

Authors:  Antonio Sagone
Journal:  J Atr Fibrillation       Date:  2015-12-31

Review 8.  Approach to antiarrhythmic therapy in patients with ICDs and frequent activations.

Authors:  Arnold Pinter; Paul Dorian
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

Review 9.  Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.

Authors:  Amir AbdelWahab; John Sapp
Journal:  Curr Cardiol Rep       Date:  2017-09-13       Impact factor: 2.931

Review 10.  Electrical storm: A clinical and electrophysiological overview.

Authors:  Sergio Conti; Salvatore Pala; Viviana Biagioli; Giuseppe Del Giorno; Martina Zucchetti; Eleonora Russo; Vittoria Marino; Antonio Dello Russo; Michela Casella; Francesca Pizzamiglio; Valentina Catto; Claudio Tondo; Corrado Carbucicchio
Journal:  World J Cardiol       Date:  2015-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.